CAS 1795037-48-7

1-[dideuterio-(2,6-difluorophenyl)methyl]triazole-4-carboxamide

Description:

1-[Dideuterio-(2,6-difluorophenyl)methyl]triazole-4-carboxamide is a chemical compound characterized by its unique structure, which includes a triazole ring and a carboxamide functional group. The presence of dideuterium indicates that two hydrogen atoms in the molecule are replaced with deuterium, a stable isotope of hydrogen, which can influence the compound's physical and chemical properties, such as its stability and reactivity. The 2,6-difluorophenyl group contributes to the compound's lipophilicity and potential biological activity, making it of interest in pharmaceutical research. The triazole moiety is known for its role in various biological applications, including as a scaffold in drug design. This compound may exhibit specific interactions with biological targets, potentially leading to therapeutic effects. Its unique isotopic labeling can also be useful in studies involving metabolic pathways or pharmacokinetics. Overall, the combination of these structural features suggests that this compound could have significant applications in medicinal chemistry and related fields.

Formula: C₁₀H₆D₂F₂N₄O

Synonyms:

• 1-[dideuterio-(2,6-difluorophenyl)methyl]triazole-4-carboxamide
• Rufinamide-[d2, 15N]

Rufinamide-15N,d2

Controlled Product

CAS: 1795037-48-7

Applications Labelled Rufinamide (R701552). Antiepileptic triazole derivative which decreases firing by neurons at sodium channels. Anticonvulsant.
References Cheung, W.K., et al.: Pharm. Res., 12, 1878 (1995), Cardot, J.-M., et al.: Biopharm. Drug Dispos., 19, 259 (1998), Palhagen, S., et al.: Epilepsy Res., 43, 115 (2001),

Formula: C₁₀H₆D₂F₂N₃₁₅NO

Color and Shape: White Solid

Molecular weight: 241.2

Ref: TR-R701552

Rufinamide-15N-d2

Controlled Product

CAS: 1795037-48-7

Rufinamide-15N-d2 is a medicinal compound that has been shown to exhibit inhibitory activity against tumor cells in human cancer cell lines. It works by targeting specific proteins involved in the growth and proliferation of cancer cells, leading to their death. Rufinamide-15N-d2 is a promising candidate for the development of new cancer inhibitors due to its ability to selectively target cancer cells while leaving healthy cells unharmed. This compound has been extensively studied in vitro and in vivo, demonstrating its potential as a powerful tool in the fight against cancer. Its effectiveness against different types of tumors makes it an excellent option for those seeking alternative treatments for their condition.

Formula: C₁₀H₈F₂N₄O

Purity: Min. 95%

Molecular weight: 241.2 g/mol

Ref: 3D-VWC03748